Noxiptiline

This classification denotes an antidepressant agent with the molecular formula C19H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DF7D3NY7EL, chemically known as 10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-on-o-(2-(dimethylamino)ethyl)oxim but generally known as noxiptiline, which bears US NIH Compound Identifier 21087. European Medicines Agency schedules Noxiptiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09386MIG. The term NOXIPTILINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). NOXIPTILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule noxiptiline under HS 29280090 and SITC 51486. As of Q4 2014, NOXIPTILINE remains the US FDA Preferred Term for this commodity. Noxiptiline bears US NLM identifiers UMLS ID C2698505 and NCI Concept Code C75174. SMILES: O(/N=C1/c2c(CCc3c1cccc3)cccc2)CCN(C)C.